Bursting bubbles for therapy: Histotripsy's Clinical Frontiers and Technological Innovations with the 2023 FDA Approval

Sunday, April 7, 2024

4:00pm – 5:30pm

Location:Governor's A - 4th Floor

A pivotal session exploring the groundbreaking advancements in histotripsy, a new therapeutic approach to tissue ablation using mechanical effects of bubbles produced by high-intensity ultrasound. This session will feature insights from leading experts—clinicians and physicists—who will delve into the latest clinical data and the underlying technology that propelled histotripsy to FDA approval and commercial availability in 2023. A subsequent panel discussion will open the floor for an interactive Q&A with the audience, offering a deep dive into the implications and opportunities of this innovative treatment.

Moderator(s)

Frederic Padilla, PhD (he/him/his)

Director, Gene and Cell Therapy Program
Focused Ultrasound Foundation
Charlottesville, United States

Session Speaker(s)

TZ

Timothy Ziemlewicz, MD

Professor
University of Wisconsin Department of Radiology
Madison, United States
Kenneth Bader, PhD

Assistant Professor
University of Chicago
Chicago, United States

Moderator(s)

J. Brian Fowlkes, PhD (he/him/his)

Professor
Radiology
University of Michigan
Ann Arbor, United States

Presentations:

4:00pm – 5:30pm

Histotripsy, Clinical
Timothy Ziemlewicz, MD – University of Wisconsin Department of Radiology
4:00pm – 5:30pm

Histotripsy, Technical
Kenneth B. Bader, PhD – University of Chicago